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Lactoferrin (Lf)t is an 80-kD iron-binding glycoprotein found in high concen-
trations inhuman milk and at much lower but detectable levels in anumber of other
secretions of glandular epithelium (1) . The principal functions of Lf are thought
to be iron transport and storage (2), and bacteriostasis through strong chelation of
iron required for microbial growth (3) . However, Lf is also a major constituent of
the secondary or specific granules of neutrophils (4), and has been implicated in
several operational and regulatory functions in theimmuneandhematopoietic systems
(5). To date, onlya single form of Lf has been described, and is presumed to account
for all of the diverse functions of the molecule.
One of us (M . R. Das) previously reported (6) the presence in human milk of
a unique and potent RNase activity, termed human milk RNase (hmRNase) . This
enzyme was initially identified basedon its interference with the detection ofretroviral-
likeRNAs in humanmilk, andwas subsequently shownto be present in lowconcen-
trations in a consanguineous community with a high incidence of breast cancer,
the Parsi women of Bombay. The hmRNase was detected in high concentrations
only in human milk and was thus considered to be potentially a marker for breast
epithelium as well as for risk to development of breast cancer.
The hmRNase has recently been purified to homogeneity and revealed to be a
high molecularmass (80 kD) glycoprotein with a preference formRNAs, viral RNAs,
and purine homopolymers (7) . Activity of the enzyme is influenced by various cat-
ions and is optimal at pHs of 7.5-8.0 .
We report here that hmRNase is an isoform of Lf, sharing physical, chemical,
and antigenic properties with the major species of Lf, but differing from it in the
possession of potent nuclease activity and in thelack of significant iron-binding ca-
pacity. These findings establish the presence of multiple forms of Lf, with very dis-
tinctive properties, that may be related to the highly diverse physiological functions
of the molecule .
This work was supportedby grants CA-33188, CA-43174, andCA-48077 from the National Institutes
of Health, and by a gift to theAMC Cancer Research Center from the Gannett Foundation .
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Materials and Methods
Materials.
￿
Human milk Lfs were obtained from Sigma Chemical Co. (St . Louis, MO) .
Rabbit antiserum against human Lfwas obtained from Accurate Chemical& Scientific Corp .
(Westbury NY). All reagents used were the highest grade commercially available . Human
milk was kindly provided by Drs . R . Ceriani and J . Peterson (John Muir Cancer and-Aging
Research Institute, Walnut Creek, CA) .
Purification ofHumanMilk RNase.
￿
The high molecular weight hmRNase was purified from
human milk as previously described (7) . Briefly, dialyzed milk plasma was chromatographed
on phosphocellulose with a linear gradient of 0.2-1.5 M NaCl. Fractions eluting between
0.7 and 0.9M NaCl, containing the ribonuclease activity, were combined and further purified
by gel filtration chromatography on Sephadex G-200 in 10mM Tris HCI, pH 7 .5 . The peak
of ribonuclease activity eluting at -80 kD was concentrated and dialyzed against 10 mM
Tris-HCl, pH 7.5 . This material was homogeneous by SDS-PAGE and devoid of contaminating
DNase, alkaline phosphatase, phosphodiesterase, or esterase activity.
SDS-PAGE .
￿
Gels (15 17o acrylamide, 0.75-mm thick) were prepared according to the method
ofLaemmli (8), and run at 7 mA in a MiniVertical Slab Apparatus (Hoefer Scientific Instru-
ments, San Franscisco, CA) . Molecular mass standards (Bio-Rad Laboratories, Richmond,
CA) were included on each gel . Gels were stained with Coomasie Blue for protein or periodic
acid-Schiff for carbohydrate .
Western Blots .
￿
SDS-PAGE gels were blotted onto nitrocellulose sheets (0.45 gm ; Schleicher
& Schuell, Inc ., Keene, NH) as previously described (9). After transfer, the sheets were blocked
by soaking in 3% BSA in PBS at room temperature for 30 min . Nitrocellulose strips were
then incubated with hybridoma culture supernatant (mAb) for 1 h at room temperature,
washed with PBS three times for 15 min each with constant rocking, incubated with horse-
radish peroxidase-conjugated goat anti-mouse Ig (diluted 1 :1,000 inPBS; Sigma Chemical
Co.), washed, and developed with 0.5% 3,3' diaminobenzidine tetrahydrochloride (Polysciences,
Inc ., Warington, PA), 0 .1 M Tris-HCI, pH 7 .2, 0.01% H202, 0.04% NiS04 .
Production ofm 4bs .
￿
8-wk-old BALB/c female mice were immunized with an intraperitoneal
injection of 10 fig purified hmRNase emulsified in Freund7s complete adjuvant . One week
later, the mice were reinjected ip with 10 ughmRNase in IFA . 2 wk later, the animals were
boosted with an intravenous injection of 10 Fig hmRNase in saline, and 2 d later, the mice
were test bled to determine antibody response byELISA (see below) . 3 d after the last antigen
injection, the spleens of mice with the highest anti-hmRNase titers were removed and their
cells fused with the myeloma line P3/NSl/1-Ag4-1, using polyethylene glycol, as described
(10) . Fused cells were selected in HAT medium . Culture supernatants were tested by ELISA
and selected hybridomas were cloned by limiting dilution . The studies reported herein were
carried out with mAbs IA-G4 and 2A-B7, both IgGls with K L chains .
ELISA .
￿
Antigen preparations (100 pl of 10 hg/ml solutions in PBS) were added to the
wells of microtiter plates and allowed to adsorb overnight at 4'C . The antigen solution was
then discarded and replaced with blocking solution (1% BSA in PBS) . After incubation for
1 h at room temperature with continuous shaking, the blocking solution was replaced with
50 pl hybridoma supernatant (diluted with an equal volume of PBS) or controls and the plates
were incubated for 1 h atroom temperature with continuous shaking . The wells were washed
three times with PBS and secondary antibody added (100 ul of alkaline phosphatase-con-
jugated goat anti-mouse Igs [Bio-Rad Laboratories] diluted 1 :1,000 in PBS) . The plates were
incubated for 1 h at room temperature and washed three times withPBS . Substrate solution
was added (1001Al of 1 mg/ml disodiump-nitrophenyl phosphate in 0.75M 2-amino-2-methyl-1,3
propanediol ; both from Sigma Chemical Co.) . The plates were read at 405 nm in an EL309
reader (BioTek Instruments, Burlington, VT) .
For inhibition assays, the same method was used except that the primary antibody was
diluted with PBS containing I% BSA to a concentration givingN50% maximum reactivity.
Aliquots (50 pl) ofthe diluted antibody were mixed with the indicated amounts ofcompeting
antigen in 50 Al PBS, incubated overnight at 4'C, and then tested for residual reactivity by
ELISA .
Partial Peptide Mapping.
￿
Proteins were compared structurally using a modification of the
partial proteolytic cleavage method (11) . Test proteins (20 lug in 20 P,1 of 1 mM Tris-HCI,FURMANSKI ET AL.
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pH 7.4) were mixed with 2 ul 1% SDS and 2 lul glycerol, and heated at 100'C for 2 min .
After cooling on ice, 5 jul of enzyme was added (0.05 mg/ml trypsin [type III ; Sigma Chem-
ical Co.] or 0 .1 mg/ml papain [type IV; Sigma Chemical Co.]) and the mixture incubated
at 37°C for 30 min with continuous shaking. The reactions were terminated by addition
of 5 A1 10% SDS, 2 tul 2-ME, and heating at 100°C for 2 min . The peptides were analyzed
by SDS-PAGE .
RNaseAssay .
￿
Samples were diluted into 40 Al buffer (20mM Tris-HCI, pH 7.4, autoclaved
and filtered through a 0.45-tum membrane filter) . Substrate ([ 3H]poly-uridylic acid, 30 Al
containing 104 cpm, 3.7 Ci/mmole uridine monophosphate ; New England Nuclear, Boston,
MA ; or 30,000 cpm 32P-poly-uridylic acid, 2.23 Ci/mmole uridine monophosphate, kindly
provided by Dr. Opendra Sharma, AMC Cancer Research Center) at 37°C for 30 min with
continuous shaking. Reactions were terminated by addition of 10 Al of 10mg/mltRNA (Sigma
Chemical Co.) and 0.5 ml ice-cold 5% TCA . The samples were held on ice for 30 min and
filtered through glass fiber filters (GF/C ; Whitman Inc., Clifton, NJ) . The filters were washed
with 5 ml ice-cold 5% TCA, dried, and counted in a scintillation spectrometer .
Iron-binding Assays.
￿
Test protein samples (5 jug in 50 pl PBS) were added to 150 p,l of 0 .1
M NaHC03 followed by 105 cpm 59Fe citrate (12.7 p.Ci/Ag Fe, New England Nuclear), and
the mixture was incubated for 1 h at 37°C with continuous shaking . Bound and unbound
59Fe were separated by chromatography on a 1 x 2-cm column ofAGl-X8 resin (Bio-Rad
Laboratories) eluted with 5 ml of 5 mM veronal buffer (5 mM Na barbital-HCI, 50mM
NaCl, pH 7.4) . Fractions of0.5 ml were collected and counted to determine protein-bound
(eluted) Fe.
Purification ofHumanMilk Lactoferrin on Cibacron Blue-Sepharose.
￿
The method used was that
previously described (3) . Briefly, 5 ml ofpooledhuman milk was skimmed and decaseinated
by centrifugation (10,000 g, 40 min), acidification (to pH 4.7 with HCI), heating (40'C, 30
min), and recentrifugation (10,000 g, 40 min) . The milkwhey was dialyzed overnight against
500 ml veronal buffer . The whey was diluted to 25 ml with veronal buffer . An aliquot (50
pl) was removed, labeled with 59Fe-citrate (see above), and added back to the remaining whey .
The entire sample was then applied to a 1 x 10-cm column of Cibacron Blue Sepharose CL-6B
(Pharmacia Fine Chemicals, Piscataway, NJ) . The column was washed with 25-ml veronal
buffer and eluted with a 30-ml linear gradient of 0.5-1 M NaCl in veronal buffer. 1-ml frac-
tions were collected for analysis . The entire procedure, with the exception ofthe heating step,
was carried out at 4 °C .
Amino Acid Sequencing
￿
The NH2-terminal amino acid sequence ofhmRNase was deter-
mined by the phenyl isothiocyanate procedure (12) using a 1090 liquid chromatography system
(Hewlett-Packard Co., Palo Alto, CA) .
Results
Characterization oftheRNase PurifiedfiomHumanMilk.
￿
RNase isolated from human
milk migrated as a single band on SDS-PAGE with a calculatedMr of 80 kD (Fig.
1) . The band stained with periodic acid-Schiff reagent, indicative of the presence
of carbohydrate . Gel fractions eluted and assayed forRNase gave a singleprominent
peak of activity corresponding to the 80-kD glycoprotein band . A minor band of
RNase activity with an M, of 14 kD was sometimes detected in the gels, which may
be a breakdown product of the 80 kD RNase (7) . The hmRNase also gave a single
prominent peak of protein and RNase activity in IEFPAGE, with pI of 8.7 .
The mAbs developed against hmRNase reacted only with the 80-kD RNase band,
as determinedby direct ELISA ofeluted SDS-PAGE gel fractions (Fig. 1), IEFPAGE
fractions, orWestern blotting (Fig. 2) . Blots ofhuman milkwhey also gave a single
band ofreactivity with themAbs, which comigrated with the reactive band obtained
usingpurifiedhmRNase . Under these conditions, no reactivity ofthemAb was seen
on blots ofhuman spleen and liver (Fig . 2) or pancreas, kidney, and serum (not shown) .
Thus, thehmRNase was a homogenous 80-kD glycoprotein, expressed primarily41 8
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FIGURE 1 .
￿
Characterization ofpuri-
fied hmRNase. (C)Coomassie Blue-
stained SDS-polyacrylamide gel of
hmRNase and molecular mass stan-
dards (phosphorylase B, 97 .4kD; BSA,
66 .2 kD ; OVA, 42 .7 kD; bovine car-
bonic anhydrase, 31 .0 kD ; soybean
trypsin inhibitor, 21 .5 kD ; heneggwhite
lysozyme, 14 .4 kD) . (B)RNase activity
of eluted fractions of hmRNase gel
(cpm [3H]poly-uridylic acid solubi-
lized minuscpm solubilized by control
[lowest gel fraction, 672 cpm]) . (A)
ELISA of eluted fractions(OD4o5 mi-
nus OD4o5 of no antigen well) .
in human milk . mAbs prepared against the hmRNase appeared to be specifically
reactive with the glycoprotein .
Identity ofhmRNase withHumanLf .
￿
In thecourse ofthese studies, astriking similarity
wasnotedbetween theproperties ofhmRNaseand oneof the majorbands ofhuman
milkon SDS-PAGE (Fig. 3) . Based on molecular weight and relative concentration,
the corresponding milk component was tentatively identified as Lf, an 80-kD iron-
binding glycoprotein present in high amounts in milk (1) .
To examine the relationship between hmRNase and Lf, we compared hmRNase
with several commercial, homogeneous preparations of authentic human Lf. The
molecules comigrated on SDS-PAGE, with calculatedM rs of 80 kD (Fig. 3), and
stained similarly with periodic acid-Schiff reagent. Subtle differences in migration
of hmRNase and different Us were sometimes noted on the gels, but overall the
characteristics ofthepreparations as determined by SDS-PAGE were thesame . The
pIs of hmRNase and Lf, determined by IEF in PAGE, were both 8.7 .
hmRNaseand Lfreacted identically with mAbs against hmRNase, as determined
by inhibition ofELISA (Fig . 4), direct ELISA, and Western blotting . Monospecific
rabbit anti-human Lf also reacted identically with LfandhmRNase in these assays
(not shown) .FURMANSKI ET AL.
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FIGURE 2 .
￿
Western blot detec-
tion of hmRNase in purified
hmRNase preparation (RN-
ase),humanmilkwhey,human
spleen extract, andhumanliver
extract using anti-hmRNase
mAb 2A-B7 or normal mouse
IgG (M-Ig) .
FIGURE 3 .
￿
SDS-PAGE of purified hmRNase, human milk whey, and
human Lf. Standards (stnd) are the same as those in Fig. 1 .
Further comparison of the composition ofhmRNase and Lfwas made by partial
proteolytic digestion and peptide analysis by SDS-PAGE . As shown in Fig. 5, the
two glycoproteins yielded identical peptide patterns after treatment with typsin or
papain . The N112-terminal amino acid sequence ofhmRNasewas determined (gly-
arg-arg-arg-arg-ser-val-glu) and found to be the same as that reported for Lf (13) .420
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FIGURE 4 .
￿
Inhibition ELISA of the
relationship betweenhmRNaseandLf
usinganti-hmRNase mAbIA-G4. (A)
purified hmRNase; (A)humanLf ;(/)
purified human lactalbumin ; (O) pu-
rified bovine lactoperoxidase.
FIGURE 5 .
￿
Comparison ofhmRNase and human Lfby partial proteo-
lytic cleavage with trypsin and papain.
By these criteria, hmRNase and Lf share physical, chemical, and antigenic prop-
erties and were, therefore, considered to be very closely related or the same .
Enzymaticand Iron-binding Properties ofhmRNaseandLf .
￿
Despite the extensive ho-
mology between the two glycoproteins, no RNase activity was detected in several
differentcommercial preparations ofhumanLf (Table I) . Removal ofiron fromRNase
or Lf,or saturation with iron under several different conditions, did not alterthe results .
In addition, hmRNase did not exhibit the major functional characteristic of Lf,
iron binding (Table II) . No iron binding by hmRNase was detected in the presence
or absence of HCO3- , using different anionic forms of Fe3+ (ferric chloride, ferric
citrate, ferric ammonium sulfate), and in the presence or absence of reducing agent
(ascorbic acid) .
Thus, although the two molecules appeared to be very similar, if not identical,
on astructural basis, they failed to coordinately express the respective primary func-
tional characteristics : hmRNase did not bind iron, and Lfhad no RNase activity.FURMANSKI ET AL.
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TABLE I
Ribonuclease Activity of Human Milk Proteins
Protein
￿
RNase activity'
Buffer only
￿
11,800
hmRNase (1 Ftg)
￿
155
human Lf (1 Wg)
￿
10,895
' TCA precipitable cpm32P-RNA remaining after 30-min incubation at 37°C.
TABLE II
Iron-binding Activity of Human Milk Proteins
Protein
￿
59Fe bound'
hmRNase (5 Wg)
￿
1,970
Human Lf (5 kg)
￿
22,391
BSA (5 14g)
￿
0
' cpm 59Fe bound minus cpm 59Fe eluting in the absence of protein (452 cpm).
Isolation ofMultiple, Functionally Distinct FormsofHuman If.
￿
The finding offunc-
tional differences between hmRNase and Lf in the face of their strong structural
similarities could be due to the existence ofmultiple forms ofLfwith distinct prop-
erties, or to selective inactivation of function (i.e., RNase or iron binding) in the
course ofpurification ofthe respective molecules. To examine these possibilities, Lf
was purified from human milk using the procedure ofBezwoda and Mansoor (14).
The salient feature ofthis method is affinity chromatography ofmilk whey on Ciba-
cron Blue F3G-A-Sepharose. Lfis identified in thechromatographic fractions based
on the presence of bound "Fe, added at the initial stages of purification.
The chromatographic pattern obtained with human milk whey is shown in Fig.
6, and is identical to that previously reported (14). A single 59Fe-containing pro-
tein peak was obtained (peak 3), which eluted at -0.75 M NaCl. Analysis of this
peak by SDS-PAGE revealed a single band that comigrated with authentic Lf. No
significant RNase activity was detected in this peak.
However, whenall thecolumn fractionswere assayed, RNase activity was detected
in two non-"Fe-containing protein peaks eluting at -0.20 and 0.40 MNaCl, peaks
1 and 2, respectively(and the unbound fractions, Fig. 6). Analysis ofthese compo-
nents by SDS-PAGE revealed essentiallyahomogeneous material comigratingwith
authenticLfandhmRNase (Fig. 7). In some preparations, peak 1 contained minor
components migrating withMrs of 115 and 64 kD. Subtle differences in the migra-
tion ofpeaks 1, 2, and 3 were observed, similar to those noted above for authentic
hmRNase and LF The RNase activity corresponded to the major protein bands
in SDS-PAGE fractions of peaks 1 and 2.
The relationship between peaks 1, 2, and 3, hmRNase, and Lfwas further exam-
ined by partialproteolytic cleavage. Peptide patterns obtained after digestion ofthe
five preparations with papain (Fig. 8) and trypsin (not shown) were identical. SDS-
PAGE bands ofall three peaks, hmRNase, and Lfstained with periodic acid-Schiff
reagent (Fig. 9). The intensity ofstaining with periodic acid-Schiff relative to pro-422
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FIGURE 6 .
￿
Purification of Lf from human milk by affinity chromatography on Cibacron Blue
F3G-A-Sepharose and analysis of fractions for protein, iron binding, and RNase activity.
FIGURE 7 .
￿
SDS-PAGE of hmRNase, Lf, and peaks 1, 2, and 3 of
affinity-purifiedhumanLf(Fig. 6) . Standards (stnd) are the same as
those in Fig . 1 .
FIGURE 8.
￿
Comparison ofhmRNase, commercial Lf, andpeaks
1, 2, and 3 of affinity-purifiedhumanmilk (Fig. 6) by partial pro-
teolytic cleavage with papain.tein staining ofthe same amount ofsample on replicate gels was slightly but reprodu-
cibly less for Lf and peak 3 than for RNase, peak 1, and peak 2.
The antigenic relationship between the different Lf-like components was exam-
ined by inhibition ELISA usinganti-hmRNase mAb2A-B7 . Allthreepeaks, as well
as hmRNase and authentic human Lf, were equally reactive (Fig. 10). The same
results were obtained using other anti-hmRNase mAbs and monospecific rabbit
anti-human Lf .
Thus, we concluded that peaks 1, 2, and 3 represent functionally distinct isoforms
of human Lf .
Interconversion ofLfIsoforms .
￿
When rechromatographed on Cibacron Blue F3G-
A-Sepharose, peaks 1, 2, and 3 eluted at the same NaCl concentrations as they did
initially. Addition or removal of Fe had no effect on the chromatographic patterns
(not shown) .
Affinity chromatography of the original hmRNase preparation, which had been
isolated by phosphocellulose and gel filtration chromatography (see Materials and
Methods), revealed the presence of all three peaks corresponding to those obtained
from human milk whey, with a predominance of peak 2 . Affinity chromatography
E
C
0
0
0
0
,ag Ag/well
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FIGURE 9 .
￿
SDS-PAGE analysis of hmRNase, Lf, and peaks 1,
2, and3 of affinity-purifiedhumanmilk (Fig. 6), and bovine lac-
toperoxidase (LP). Gelwas stained with periodic acid-Schiffreagent .
FIGURE 10.
￿
Inhibition ELISA ofthe
relationship betweenhmRNase (A), Lf
(A), peaks 1 ("), 2
￿
and 3 (*),
human lactalbumin
￿
and bovine
lactoperoxidase (O), using anti-hm-
RNasemAb 1A-G4 .424
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FIGURE 11 .
￿
Affinity chromatography ofcommercial human Lf (Sigma Chemical Co .) on Ciba-
cron Blue F3G-A-Sepharose .
of commercial human Lf (No. L3639 ; Sigma Chemical Co.), which lacks RNase
activity, yielded a single 59Fe-binding protein peak, eluting at the same NaCl con-
centration as peak 3 from human milk, and no detectable amounts of peaks 1 and
2 (Fig . 11) .
Discussion
These studies were originally undertaken with the purpose of characterizing an
unusual RNase activity inhuman milks . The enzyme hadpreviously been reported
to be expressed in low concentrations in the milks of Parsi women (6), a consan-
guineous population in Bombay with a particularly high incidence of breast cancer
relative to other communities in India. Thus, it was considered thathmRNase might
serve as amarker for breast cancer risk, or because of its apparent highly restricted
tissue distribution, as a marker for human mammary epithelium . In the course of
these studies, we found that hmRNase is a functionally distinct isoform of Lf.
LfandhmRNaseexhibited very similar, ifnot identical, migrations in SDS-PAGE,
IEFPAGE, partial peptide maps, N142-terminal amino acid sequences, and reac-
tivities with a panel of anti-hmRNase mAbs and monospecific anti-Lf antiserum .
The preparations could be resolved into three distinct Lf isofrm by affinity chro-
matography, with one form having the characteristics of conventional Lf and the
other two exhibiting RNase activity and no iron binding .
Lf, identified originally as the majoriron-binding constituent of milk (1), and serving
a major physiological role in iron storage and transport in lactation, has also been
implicated inawide varietyofother functions involvinganumber ofdifferent organ
systems (5). Lf is a significant component of the secondary granules of neutrophils
(4) and is thought to play a major role in antimicrobial activity of granulocytic cells
(3) and milk (15) by chelating iron required for microbial growth . The affinity ofFURMANSKI ET AL.
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Lfforironisgreaterthan thatoftransferrin(1), and thus, Lfremoves both available,
freeiron as well asboundiron from plasma ormilk. After release from granulocytes
and saturation with iron, Lfisremoved from the circulationby thereticuloendothelial
system through specific receptors for iron-saturated Lf(16). This is thought to be
a mechanism ofthe hyposiderinemiaaccompanying an acuteinflammatory response.
Since neutrophil degranulation is considered to be the only source of circulating
Lf(17), serum Lf levels have been proposed as a measure of inflammation or the
acute phase response (18, 19), and the size of the total granulocyte pool (20).
Hematopoietic regulatory functions have also been ascribed to Lf. Broxmeyer et
al. (21) have shown that Fe-saturated Lfbinds to receptors on macrophages and in-
hibits their release ofGM-CSF In vivo, Lf decreases myelopoiesis in normal mice
anddampensrebound myelopoiesis in animals treatedwith cyclophosphamide (22).
Lfinhibits replication ofthe SFFV component ofthe Friend erythroleukemia virus
complex and prolongs survival ofmice infected with the virus (23). Abnormalities
in Lfproductionand inresponsiveness toLfhave been detected inleukemia patients
(24, 25).
In addition, Lfhas been shown to promote neutrophil adhesiveness, reduce lyso-
zyme regeneration, stimulate NK activity, suppress in vitro primary immune re-
sponses, enhance growth ofcertain human lymphoid cells in culture, and decrease
numbers and replication ofearlyerythroid colony-forming cells and multipotential
hematopoietic progenitors, among other activities (reviewed in references 5, 26, 27).
Someoftheseeffects maybemediated through Lfsuppression ofIL-1 production (5).
Ambruso andJohnston (28) reported that Lfcatalyzes hydroxyl radical produc-
tion from superoxide anion and hydrogen peroxide. This activity was detected in
both milk Lfand neutrophil Lf, and required Fe saturation. Production ofhydroxyl
radical may be involved in antimicrobial activity as well as tissue injury occurring
at sites of inflammation.
Until now, all ofthese varied functions ofLfhave been attributedto asingle mole-
cule. Lfs isolated from human milk and human neutrophils were reported to have
the same Mr, pI, reactivity with monospecific antibody, and clearance from the cir-
culation (29). However, Broxmeyer et al. (27) found a small, but consistent differ-
ence in migration ofmilk andneutrophil Lfon SDS-PAGE, and Ambruso andJohn-
ston(28) found that neutrophil Lfcatalysis ofhydroxylradical production was optimal
at 10-fold lower concentrations than milk Lf. We have detected small differences in
the migration of Lfpeaks 1, 2, and 3 on SDS-PAGE that may be due to the differ-
ences in iron content (although this would represent an Mr difference of only
-0.15%) or changes in carbohydrate composition.
The amino acid sequence of Lfhas been determined (13). The protein consists
of 703 amino acid residues, which comprise two domains, each with a single Fe-
bindingsiteand an N-glycosylation site. A partial cDNA clone for Lfhas been iso-
lated fromhumanmyeloid leukemia cells(30). Numbers ofLfgenes ortheir organi-
zation have not yet been reported. There are no apparent relationships between the
amino acid sequence of Lf and known RNases.
The nature ofthe structural differences that give rise to the profound functional
changes in the isoforms of Lf are not known. It does not appear that they are due
to Fe, since neither removal nor addition of Fe had any effect on RNase activity.
The fact that peaks 1, 2, and 3 gave the same partial proteolytic digestion patterns426
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and NH2-terminal sequence suggests that the primary amino acid structures of the
isoforms are very similar, although small differences obviously cannot be detected
in this way. All three forms stain with periodic acid-Schiff reagent, demonstrating
that all are glycoproteins, butneither quantitative nor qualitative differences in car-
bohydrate content can be ruled out at this time; a small but consistent difference
in the ratio of periodic acid Schiff (PAS) stain intensity to the amount of protein
on the gelhas been observed. Otherpost-translational modifications, includingphos-
phorylation, could also be involved in the functional differences among the isoforms.
The finding of a single polypeptide, or closely related congeners, with multiple
discrete functions is notitself novel. Many examples existof genes that become dupli-
cated, diverge, and evolve into homologous but functionally distinct entities. There
are also severalexamples of a single gene/polypeptide with both structural or regula-
tory and enzymatic functions in different tissues, including lens crystallins shown
to be identical with certain metabolic enzymes (31-33), and the identity between
neuroleukin and glucosephosphate isomerase (34, 35).
The precise relationship of the RNase activity of two of the forms of Lf to the
variousproposed functionsofthe glycoprotein also remainsto be determined. Nuclease
activity could obviously play a role in microbial degradation or inflammation. Lf
bindsto DNA (36) and to cell membrane DNA on B cells (37) and neutrophils(38),
as does hmRNase (7), which implies a nucleic acid recognition capacity for the pri-
mary molecule that could be related to itsenzymatic and regulatory activities. Fur-
thermore, whilesome investigators have shown localization ofLfin the specific granules
of neutrophils (4), others have reported its presence in neutrophil nuclei (39), also
suggestive of a regulatory role related to nucleic acid recognition.
hmRNase was initially detected primarily in human milk. The lack of detection
of material reactive with the hmRNase mAb in human spleen extracts (Fig. 1) or
other tissues was due to the fact that the concentration of Lf (hmRNase) in milk
is -1,000-fold higher than in granulocytes (1). Studies with granulocytes purified
from human peripheral blood have revealed the presence of all three isoforms of
Lfdetermined by Cibacron Blue-Sepharose chromatography (unpublished results).
In addition, Western blots of extracts of purified human granulocytes and im-
munofluorescent staining of human peripheral blood smears with mAbs directed
against hmRNase demonstrated specific immunoreactive material in granulocytes.
Thus, Lf, amolecule with aparticular tissue distribution andnumerous proposed
metabolicandregulatory functions, exists in multiple formswith distinctive proper-
ties. We propose the followingnomenclature for these isoforms of L£: lactoferrin-a,
thetraditional iron-binding form (peak 3); lactoferrin-/3, the RNase, non-iron-binding
form ofLfeluting from Cibacron Blue Sepharoseat 0.40MNaCl (peak2); lactoferrin-
-y, the RNase, non-iron-binding form ofLfeluting at 0.20 M NaCl (peak 1). Studies
are presently in progress to further define the comparative structures of the three
Us and to relate their properties to the varied functions of the molecule.
Summary
Lactoferrin(Lf), themajoriron-binding component ofmilk, also amajorconstit-
uent of the specific granules of neutrophils involved in antimicrobial activity and
a glycoprotein thought to play a role in regulatory functions in the hematopoieticFURMANSKI ET AL .
￿
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system as well as other physiologic activities, is shown to occur in three isoforms.
One, Lf-a, binds iron ; the other two, Lf-ß and Lf-y, express potent RNase activity,
but do not bind iron . The three isoforms are very similar or identical in Mr , pl,
partial proteolytic peptide patterns, NF12-terminal amino acid sequence, and reac-
tivity with mAbs and polyclonal antisera against the RNase and Lf, respectively .
The finding of structurally similar but enzymatically distinct forms ofLf may be
related to the diverse functions of the molecule.
We thank Drs . Opendra Sharma and Randall Cohrs (Laboratory of Molecular Biology, AMC
Cancer Research Center) for their help with the RNase assays, Victor Ozols for excellent
assistance in development and screening ofthehybridomas, Clifford Longley for help in pho-
tographing the gels, and Cathy Allen for preparation of the manuscript .
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